Cited by 136PI3K/AKT/mTOR signaling in cancerCell death mechanisms and regulationHippo pathway signaling and YAP/TAZ

The pro‐apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1

Open access
Cinar, Bekir, Fang, Ping‐Ke, Lutchman, Mohini, Di Vizio, Dolores, Adam, Rosalyn M, Pavlova, Natalya, Rubin, Mark A, Yelick, Pamela C +1 more·2007·The EMBO Journal

Abstract

Akt kinases mediate cell growth and survival. Here, we report that a pro-apoptotic kinase, Mst1/STK4, is a physiological Akt1 interaction partner. Mst1 was identified as a component of an Akt1 multiprotein complex isolated from lipid raft-enriched fractions of LNCaP human prostate cancer cells. Endogenous Mst1, along with its paralog, Mst2, acted as inhibitors of endogenous Akt1. Surprisingly, mature Mst1 as well as both of its caspase cleavage products, which localize to distinct subcellular compartments and are not structurally homologous, complexed with and inhibited Akt1. cRNAs encoding full-length Mst1, and N- and C-terminal caspase Mst1 cleavage products, reverted an early lethal phenotype in zebrafish development induced by expression of membrane-targeted Akt1. Mst1 and Akt1 localized to identical subcellular sites in human prostate tumors. Mst1 levels declined with progression from clinically localized to hormone refractory disease, coinciding with an increase in Akt activation with transition from hormone naïve to hormone-resistant metastases. These results position Mst1/2 within a novel branch of the phosphoinositide 3-kinase/Akt pathway and suggest an important role in cancer progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.emboj.7601872

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 51 · Cited by 136

Authors
Cinar, B., Fang, P., Lutchman, M., Di Vizio, D., Adam, R. M., Pavlova, N., Rubin, M. A., Yelick, P. C., & Freeman, M. R.
Affiliations
  • Boston Children's Hospital (US)
  • Harvard University (US)
  • Brigham and Women's Hospital (US)
  • Tufts University (US)
Corresponding author
Freeman, Michael R
Venue
The EMBO Journal
Published
2007-10-11
Volume
26
Issue
21
Pages
4523-4534
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2106401943
Cited by
136
References
51
Citations by year
2026: 5 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 9 · 2013: 10 · 2012: 8
FWCI
3.18
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense (W81XWH)
  • American Urological Association Foundation
  • American-Italian Cancer Foundation
  • National Institutes of Health (5r01ca112303-05, W81XWH, CA112303)
  • National Cancer Institute (R01-CA-112303)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK47556, P50DK65298, R37DK047556, P50DK065298)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
Keywords
MST1, MST2, AKT1, kinase inhibition, phosphoinositide 3-kinase/Akt pathway, prostate cancer, castration-resistant prostate cancer, apoptosis, lipid rafts, tumor progression, protein-protein interaction
MeSH terms
Hippo Kinases, Animals, Humans, Male, Models, Biological, Phenotype, Zebrafish, Gene Expression Regulation, Neoplastic, Apoptosis, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Disease Progression, Caspases, Membrane Microdomains, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Proto-Oncogene Proteins c-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review